Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Laurus Labs May Rally 35% Says Motilal Oswal — Key Triggers And Target Price Inside

    1 week ago

    Laurus is witnessing a strong scale-up in CDMO business from global innovator pharma, including rare formulation-level contracts for patented products, adds Motilal Oswal.
    Click here to Read More
    Previous Article
    The Weight Loss Price Cut Begins — NATCO Launches Semaglutide At Rs 1,290
    Next Article
    Government Opens Bid For Rs 7,300-Crore Scheme For Rare Earth Magnets

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment